Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.

Ambati BK, Anand A, Joussen AM, Kuziel WA, Adamis AP, Ambati J. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci. 2003 Feb; 44(2):590-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.